These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7191570)

  • 1. Effects of thioridazine on apomorphine-elicited stereotypic behavior and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    Pharmacol Biochem Behav; 1980 Sep; 13(3):397-401. PubMed ID: 7191570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H; Carino MA; Horita A
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC; Davis JM
    Life Sci; 1976 Sep; 19(5):725-31. PubMed ID: 986527
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC; Carino MA; Horita A
    Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic-induced dopamine hyposensitivity.
    Goetz CG; Carvey PM; Tanner CM; Klawans HL
    Life Sci; 1984 Apr; 34(15):1475-9. PubMed ID: 6538629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL; Carvey PM; Nelson D; Tanner CM; Goetz CG
    Life Sci; 1986 May; 38(19):1707-14. PubMed ID: 3702600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
    Amabeoku GJ
    Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of haloperidol and thioridazine on apomorphine- and LSD-induced hyperthermia in the rabbit.
    Roszell DK; Horita A
    J Psychiatr Res; 1975 Aug; 12(2):117-23. PubMed ID: 1171973
    [No Abstract]   [Full Text] [Related]  

  • 10. Thioridazine chronic administration: a behavioural and autoradiographic study.
    Calzà L; Giardino L; Piazza PV; Amato G
    Neurosci Lett; 1990 Feb; 109(1-2):206-11. PubMed ID: 2314636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computer-supported method for analyzing behavioral observations: studies with stereotypy.
    Lewis MH; Baumeister AA; McCorkle DL; Mailman RB
    Psychopharmacology (Berl); 1985; 85(2):204-9. PubMed ID: 3925484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and post-synaptic actions of apomorphine: differentiation by rotatory effects in normal rats.
    Glick SD; Jerussi TP; Cox RD; Fleisher LN
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):303-7. PubMed ID: 557962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M; Leonard BE
    J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):418-29. PubMed ID: 576565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity.
    Wilcox RE; Smith RV; Anderson JA; Riffee WH
    Pharmacol Biochem Behav; 1980 Jan; 12(1):29-33. PubMed ID: 7189285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Oct; 25(4):757-61. PubMed ID: 2878442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.